
1. virology. 2005 sep 1;339(2):281-8.

human apobec3b potent inhibitor hiv-1 infectivity resistant to
hiv-1 vif.

doehle bp(1), sch√§fer a, cullen br.

author information: 
(1)center virology, duke university medical center, durham, nc 27710, usa.

while human antiretroviral defense factors apobec3f apobec3g potent
inhibitors replication hiv-1 mutants lacking functional vif gene, the
vif protein expressed wild-type hiv-1 blocks function host cell
proteins. here, report third human protein, apobec3b, able to
suppress infectivity vif-deficient wild-type hiv-1 equal
efficiency. apobec3b, shows approximately 58% sequence identity both
apobec3f apobec3g, shares ability human proteins bind
the nucleocapsid domain hiv-1 gag specifically thereby package into
progeny virion particles. however, apobec3b differs apobec3f apobec3g in
that unable bind hiv-1 vif co-expressing cells therefore
efficiently packaged hiv-1 virions regardless vif expression.
unfortunately, apobec3b also differs apobec3f apobec3g not
normally expressed lymphoid cells serve targets hiv-1
infection. studies therefore raise possibility activation the
endogenous apobec3b gene primary human lymphoid cells could form novel and
effective strategy inhibition hiv-1 replication vivo.

doi: 10.1016/j.virol.2005.06.005 
pmid: 15993456  [indexed medline]

